サマリー

皮膚科用医薬品の世界市場 2022-2026 年
Technavioは皮膚科治療薬市場を監視しており、2022-2026年の間に193億3000万ドルの成長が見込まれ、予測期間中に14.67％のCAGRで加速しています。当レポートでは、皮膚科治療薬市場の全体分析、市場規模・予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、最小限のモニタリングで済む安全で安定した薬剤へのニーズ、診断方法の改善、手頃な価格の皮膚科治療へのニーズが原動力となっています。
皮膚科治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの皮膚科治療薬市場は、以下のように区分されています。
製品別
- 生物製剤
- 低分子化合物
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、皮膚科治療薬の価格上昇が、今後数年間の皮膚科治療薬市場の成長を促進する主要な理由の1つであると認識しています。また、主要薬剤の特許切れや治療用の生物学的製剤/バイオシミラーの利用が可能であることも、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。皮膚科治療薬市場に関する弊社のレポートは、以下の分野を対象としています。
- 皮膚科治療薬市場のサイジング
- 皮膚科治療薬市場の予測
- 皮膚科治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie、Amgen Inc.、Bausch Health Companies Inc.、Botanix Pharmaceutical、Bristol Myers Squibb Co,Cipla Ltd.、Dr. Reddys Laboratories Ltd.、F. Hoffmann La Roche Ltd.、Galderma SA、GlaxoSmithKline Plc、Johnson and Johnson、LEO Pharma AS、Lupin Ltd、Novartis AG、Pfizer Inc、Sanofi SA、Sol-Gel Technologies Ltd、Sun Pharmaceutical Industries Ltd、UCB SAおよびVibcare Pharma Pvt. Ltd.などのベンダーがあります。また、皮膚科治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/dermatological-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Biologics - Market size and forecast 2021-2026
o Exhibit 28: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Biologics - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
o 5.4 Small molecules - Market size and forecast 2021-2026
o Exhibit 32: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Finland - Market size and forecast 2021-2026
o Exhibit 62: Chart on Finland - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Finland - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Finland - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Finland - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie
o Exhibit 85: AbbVie - Overview
o Exhibit 86: AbbVie - Product / Service
o Exhibit 87: AbbVie - Key offerings
o 10.4 Amgen Inc.
o Exhibit 88: Amgen Inc. - Overview
o Exhibit 89: Amgen Inc. - Product / Service
o Exhibit 90: Amgen Inc. - Key offerings
o 10.5 Bristol Myers Squibb Co.
o Exhibit 91: Bristol Myers Squibb Co. - Overview
o Exhibit 92: Bristol Myers Squibb Co. - Product / Service
o Exhibit 93: Bristol Myers Squibb Co. - Key offerings
o 10.6 Galderma SA
o Exhibit 94: Galderma SA - Overview
o Exhibit 95: Galderma SA - Product / Service
o Exhibit 96: Galderma SA - Key news
o Exhibit 97: Galderma SA - Key offerings
o 10.7 Johnson and Johnson
o Exhibit 98: Johnson and Johnson - Overview
o Exhibit 99: Johnson and Johnson - Business segments
o Exhibit 100: Johnson and Johnson - Key news
o Exhibit 101: Johnson and Johnson - Key offerings
o Exhibit 102: Johnson and Johnson - Segment focus
o 10.8 LEO Pharma AS
o Exhibit 103: LEO Pharma AS - Overview
o Exhibit 104: LEO Pharma AS - Business segments
o Exhibit 105: LEO Pharma AS - Key offerings
o Exhibit 106: LEO Pharma AS - Segment focus
o 10.9 Novartis AG
o Exhibit 107: Novartis AG - Overview
o Exhibit 108: Novartis AG - Business segments
o Exhibit 109: Novartis AG - Key offerings
o Exhibit 110: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 111: Pfizer Inc. - Overview
o Exhibit 112: Pfizer Inc. - Product / Service
o Exhibit 113: Pfizer Inc. - Key news
o Exhibit 114: Pfizer Inc. - Key offerings
o 10.11 Sanofi SA
o Exhibit 115: Sanofi SA - Overview
o Exhibit 116: Sanofi SA - Business segments
o Exhibit 117: Sanofi SA - Key news
o Exhibit 118: Sanofi SA - Key offerings
o Exhibit 119: Sanofi SA - Segment focus
o 10.12 UCB SA
o Exhibit 120: UCB SA - Overview
o Exhibit 121: UCB SA - Product / Service
o Exhibit 122: UCB SA - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Finland - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Finland - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Finland - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Finland - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie - Overview
Exhibits86: AbbVie - Product / Service
Exhibits87: AbbVie - Key offerings
Exhibits88: Amgen Inc. - Overview
Exhibits89: Amgen Inc. - Product / Service
Exhibits90: Amgen Inc. - Key offerings
Exhibits91: Bristol Myers Squibb Co. - Overview
Exhibits92: Bristol Myers Squibb Co. - Product / Service
Exhibits93: Bristol Myers Squibb Co. - Key offerings
Exhibits94: Galderma SA - Overview
Exhibits95: Galderma SA - Product / Service
Exhibits96: Galderma SA - Key news
Exhibits97: Galderma SA - Key offerings
Exhibits98: Johnson and Johnson - Overview
Exhibits99: Johnson and Johnson - Business segments
Exhibits100: Johnson and Johnson - Key news
Exhibits101: Johnson and Johnson - Key offerings
Exhibits102: Johnson and Johnson - Segment focus
Exhibits103: LEO Pharma AS - Overview
Exhibits104: LEO Pharma AS - Business segments
Exhibits105: LEO Pharma AS - Key offerings
Exhibits106: LEO Pharma AS - Segment focus
Exhibits107: Novartis AG - Overview
Exhibits108: Novartis AG - Business segments
Exhibits109: Novartis AG - Key offerings
Exhibits110: Novartis AG - Segment focus
Exhibits111: Pfizer Inc. - Overview
Exhibits112: Pfizer Inc. - Product / Service
Exhibits113: Pfizer Inc. - Key news
Exhibits114: Pfizer Inc. - Key offerings
Exhibits115: Sanofi SA - Overview
Exhibits116: Sanofi SA - Business segments
Exhibits117: Sanofi SA - Key news
Exhibits118: Sanofi SA - Key offerings
Exhibits119: Sanofi SA - Segment focus
Exhibits120: UCB SA - Overview
Exhibits121: UCB SA - Product / Service
Exhibits122: UCB SA - Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations